BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36661732)

  • 1. Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature.
    Virarkar M; Vulasala SS; Calimano-Ramirez L; Singh A; Lall C; Bhosale P
    Curr Oncol; 2023 Jan; 30(1):1077-1105. PubMed ID: 36661732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Positron Emission Tomography/Magnetic Resonance Imaging in Gynecological Malignancies.
    Virarkar M; Viswanathan C; Iyer R; de Castro Faria S; Morani A; Carter B; Ganeshan D; Elsherif S; Bhosale PR
    J Comput Assist Tomogr; 2019; 43(6):825-834. PubMed ID: 31453978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis.
    Virarkar M; Ganeshan D; Devine C; Bassett R; Kuchana V; Bhosale P
    Clin Imaging; 2020 Mar; 60(1):53-61. PubMed ID: 31864201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
    Nakajo K; Tatsumi M; Inoue A; Isohashi K; Higuchi I; Kato H; Imaizumi M; Enomoto T; Shimosegawa E; Kimura T; Hatazawa J
    Jpn J Radiol; 2010 Feb; 28(2):95-100. PubMed ID: 20182843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic imaging using positron emission tomography for gynecological malignancy.
    Tsuyoshi H; Yoshida Y
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1687-1699. PubMed ID: 28884883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study.
    Schwartz M; Gavane SC; Bou-Ayache J; Kolev V; Zakashansky K; Prasad-Hayes M; Taouli B; Chuang L; Kostakoglu L
    Abdom Radiol (NY); 2018 Dec; 43(12):3462-3467. PubMed ID: 29948057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
    Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Different Imaging Techniques for Detection of Para-Aortic Lymph Node Metastasis from Gynecological Malignancies: A Systematic Review and Meta-Analysis.
    Gong Y; Guo Z; Tang X; Li C; Wang Q
    Gynecol Obstet Invest; 2020; 85(1):53-71. PubMed ID: 31505492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography-computed tomography imaging for malignancies in women.
    Viswanathan C; Bhosale PR; Shah SN; Vikram R
    Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography/MRI for cardiac diseases assessment.
    Manabe O; Oyama-Manabe N; Tamaki N
    Br J Radiol; 2020 Sep; 93(1113):20190836. PubMed ID: 32023123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in [¹⁸F]FDG PET imaging in gynecological malignancies.
    Hernandez Pampaloni M; Facchetti L; Nardo L
    Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):124-38. PubMed ID: 26937887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT and radiotherapy in gynecological cancer.
    Caroli P; Fanti S
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):533-42. PubMed ID: 20927020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET and PET-CT imaging of gynecological malignancies: present role and future promise.
    Basu S; Li G; Alavi A
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):75-96. PubMed ID: 19105709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis.
    Nie J; Zhang J; Gao J; Guo L; Zhou H; Hu Y; Zhu C; Li Q; Ma X
    PLoS One; 2017; 12(5):e0175401. PubMed ID: 28481958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.
    Bagade S; Fowler KJ; Schwarz JK; Grigsby PW; Dehdashti F
    Semin Nucl Med; 2015 Jul; 45(4):293-303. PubMed ID: 26050657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of imaging in pelvic exenteration for gynecological cancers.
    Causa Andrieu PI; Woo S; Rios-Doria E; Sonoda Y; Ghafoor S
    Br J Radiol; 2021 Sep; 94(1125):20201460. PubMed ID: 33960814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.
    Sadowski EA; Pirasteh A; McMillan AB; Fowler KJ; Kusmirek JE
    Abdom Radiol (NY); 2022 Sep; 47(9):3189-3204. PubMed ID: 34687323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.